Case 3-2017. A 62-Year-Old Man with Cardiac Sarcoidosis and New Diplopia and Weakness.

A 62-year-old man with sarcoidosis was admitted to this hospital because of diplopia and weakness. Examination of the CSF revealed elevated opening pressure and leukocytosis. The patient’s condition deteriorated rapidly. He died 10 days later. A diagnosis was made.

[1]  W. Hikal,et al.  Evaluation of Ozone Application in Dental Unit Water Lines Contaminated with Pathogenic Acanthamoeba , 2015, Iranian journal of parasitology.

[2]  J. Cope.  Investigational Drug Available Directly from CDC for the Treatment of Infections with Free-Living Amebae , 2013, MMWR. Morbidity and mortality weekly report.

[3]  J. Bilbao,et al.  Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier. , 2012, The American journal of tropical medicine and hygiene.

[4]  Azza Hassan,et al.  Acanthamoeba contamination of hemodialysis and dental units in Alexandria, Egypt: a neglected potential source of infection. , 2012, Journal of infection and public health.

[5]  J. Walochnik,et al.  Granulomatous Amebic Encephalitis in a Child with Acute Lymphoblastic Leukemia Successfully Treated with Multimodal Antimicrobial Therapy and Hyperbaric Oxygen , 2010, Journal of Clinical Microbiology.

[6]  H. Auer,et al.  Acute Granulomatous Acanthamoeba Encephalitis in an Immunocompetent Patient , 2010, Neurocritical care.

[7]  H. Prosch,et al.  Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine , 2008, Emerging infectious diseases.

[8]  J. Sejvar,et al.  The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Combes,et al.  Fatal Disseminated Acanthamoeba lenticulata Acanthamebiasis in a Heart Transplant Patient , 2007, Emerging infectious diseases.

[10]  F. Schuster,et al.  Inability To Make a Premortem Diagnosis of Acanthamoeba Species Infection in a Patient with Fatal Granulomatous Amebic Encephalitis , 2005, Journal of Clinical Microbiology.

[11]  G. Cabral,et al.  Acanthamoeba spp. as Agents of Disease in Humans , 2003, Clinical Microbiology Reviews.

[12]  Shyam Sundar,et al.  Oral miltefosine for Indian visceral leishmaniasis. , 2002, The New England journal of medicine.

[13]  G. Visvesvara,et al.  Granulomatous Amebic Encephalitis in a Patient with AIDS: Isolation of Acanthamoeba sp. Group II from Brain Tissue and Successful Treatment with Sulfadiazine and Fluconazole , 2000, Journal of Clinical Microbiology.

[14]  G. Visvesvara,et al.  Brief report: successful treatment of disseminated acanthamoeba infection in an immunocompromised patient. , 1994, The New England journal of medicine.

[15]  C. Paddock,et al.  Cutaneous Acanthamoebiasis with CNS Involvement Post- Transplantation: Implication for Differential Diagnosis of Skin Lesions in Immunocompromised Patients , 2012 .

[16]  G. Visvesvara.  Free-Living Amebae as Opportunistic Agents of Human Disease , 2010 .